Kirsa Skov-Jeppesen

6PUBLICATIONS
36CO-AUTHORS
Nutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 13, 2024
Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.

Kirsa Skov-Jeppesen, Charlotte B Christiansen, Laura S Hansen

|Jan 18, 2023
The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans.

Liva S L Krogh, Kristine Henriksen, Signe Stensen

|Sep 16, 2022
GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes.

Sebastian Møller Nguyen Heimbürger, Bjørn Hoe, Chris Neumann Nielsen

|Apr 22, 2021
Effects of endogenous GIP in patients with type 2 diabetes.

Signe Stensen, Lærke S Gasbjerg, Liva L Krogh

|Apr 14, 2021
The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypoparathyroidism-A Randomized Crossover Study.

Kirsa Skov-Jeppesen, Nicola Hepp, Jannika Oeke

Pageof 1